logo
Under Trump Administration Full Coverage Of HIV PrEP Drugs Uncertain

Under Trump Administration Full Coverage Of HIV PrEP Drugs Uncertain

Forbes04-05-2025

PrEP is used to prevent HIV infection.
The Supreme Court heard oral arguments last month in a case that could affect what kinds of preventive care services, technologies and medicines are covered at no charge to the patient as a result of provisions contained in the Affordable Care Act. This includes cancer screenings such as mammograms and colonoscopies, statins for heart disease, immunizations, counseling on health behaviors related to weight management, alcohol and drug use, prenatal testing and HIV prevention (preexposure prophylaxis) medications.
The case was brought by Braidwood Management, a Christian for-profit corporation owned by Steven Hotze, a Texas doctor and Republican activist who has previously filed multiple lawsuits against the ACA. While the Trump administration is defending the ACA law in the case in question, should the federal government win, the precise shape preventive care coverage requirements will take depends on the discretion of Secretary of Health and Human Services, Robert F. Kennedy. This is particularly relevant with respect to PrEP, as the administration has been cutting funds earmarked for HIV prevention, including treatment and research.
PrEP is nearly 100% effective at preventing infection. This facilitated it being covered at no cost for millions of people. Moreover, several large trials have demonstrated that a treatment called lenacapavir can also prevent HIV transmission with just two injections annually. The product is expected to be approved by the Food and Drug Administration for prevention later this year. However, it's uncertain whether free access will be guaranteed.
The plaintiffs in the Braidwood case challenged the ACA's requirement to cover preventive services, as explained in an issue brief published by KFF. In particular, the plaintiffs object to providing their 70 employees fully reimbursed access to PrEP. They argue that religious beliefs prevent them from doing so. Correspondingly, they allege that the requirement violates the Religious Freedom Restoration Act.
They further maintain that the U.S. Preventive Services Task Force is unconstitutional because its members are not appointed by the president or confirmed by the Senate. The Supreme Court is specifically considering whether USPSTF's structure violates the U.S. Constitution's Appointments Clause. USPSTF is an independent entity that makes recommendations regarding whether public health insurance programs should include certain preventive services. And the ACA requires all insurers, including those in the commercial sector as well as self-insured employers, to cover preventive services and technologies that are recommended by the USPSTF with no patient cost-sharing.
Besides public programs such as Medicare and Medicaid, a number of ACA requirements extend to the commercial sector. This means that over 150 million Americans with commercial health insurance can gain access to free preventive care through the ACA.
Under successive administrations, the federal government has argued that the USPSTF's oversight by the Secretary of Health and Human Services is constitutionally appropriate because HHS may remove members at will and can determine when health insurance issuers must start providing coverage for new recommendations.
Should the administration prevail in the current case, it's unclear what Kennedy will do to affect the precise coverage criteria for preventive care, including PrEP. The Secretary of HHS has considerable influence regarding the composition of the USPSTF task force and can support or override its recommendations. This has the potential to determine whether PrEP is available at no cost to patients and how generous the coverage is. For example, does an older, cheaper PrEP product get recommended over a newer, more expensive drug?
What may give pause are the large cuts that Kennedy has instituted across HHS agencies, which include substantial reductions in funding for HIV prevention, as reported by Politico. The secretary has also called for an eight-year pause in infectious disease research. And perhaps most notably, past remarks of Kennedy seem to question a causal relationship between HIV and AIDS. Moreover, the President's Emergency Plan for AIDS Relief or PEPFAR, a global health program initiated 20 years ago by President George W. Bush, is presently barred under an order from the Trump administration from providing PrEP to LGBTQ+ people. The program may only provide pregnant and breast-feeding women with PrEP.
It's not just the executive branch that is raising questions about the future of PrEP coverage. Republican lawmakers have signaled intentions to cut or alter a variety of healthcare programs that deliver PrEP. Last year, for example, the House of Representatives proposed $770 million in cuts to HIV-specific programs. GOP legislators are also talking about measures such as putting hard caps on Medicaid funding to states or diminishing the federal matching rate. Medicaid is a key payer in the HIV space.
Experts suggest that raising access or cost barriers for PrEP would disproportionately harm younger patients, people of color and those with lower incomes. Compounding this problem, the challenge in public health—particularly around diseases such as HIV—is often getting the message across to people in the most vulnerable communities, where disease and treatment awareness may already be subpar. Substantial reductions in funding for HIV prevention efforts could further hamper this public health messaging.
Insurance contracts are typically written and defined by calendar year, so whatever happens regarding the court case, people won't see changes until 2026. Also, these services will still likely have to be reimbursed to some degree by health insurers as essential health benefits through a separate provision of the ACA. But they may not be free anymore and the comprehensiveness of coverage could be curtailed as under the essential health benefits clause, usually only one item in each therapeutic class has to be included.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Modesto City Schools trustee is critical of sex education plan for 5th-graders
Modesto City Schools trustee is critical of sex education plan for 5th-graders

Yahoo

time7 hours ago

  • Yahoo

Modesto City Schools trustee is critical of sex education plan for 5th-graders

A Modesto City Schools board member wants parents to know what's in a sex education curriculum designed for fifth-grade classrooms. Jolene Daly spoke at two recent gatherings, arguing that fifth-graders aren't psychologically prepared for the content about gender identity and sexual activity. Daly gave a scathing critique of the curriculum Saturday at Celebration Center, a church in Modesto. She said she spoke as a licensed family therapist, not as a school board member. 'It oversexualizes 10-year-olds,' Daly said. 'These children are not ready for this material.' The proposed fifth-grade sex education curriculum in Modesto City Schools is likely to run into some opposition several months after Stanislaus County voters swung conservative in the November presidential election and the culture wars were one of the issues. About 50 people attended Daly's talk at Celebration Center and more than 100 were at a June 2 event, she said. Several people at Saturday's presentation asked how to get involved with the school district's decision-making process. MCS trustees this month will consider two curriculum options: 'Puberty Talk for Grades 5 & 6' and 'Puberty: The Wonder Years, Grade 5.' A 16-member committee consisting of teachers, parents and board members reviewed curriculum choices and has recommended 'Puberty Talk.' The proposed sex education is under the school district's fifth-grade health curriculum, which focuses on hygiene, nutrition, puberty, internet safety, social influences, healthy communication and relationships. According to an MCS FAQ page, the California Healthy Youth Act also requires sex education topics when school districts offer health education. The classroom instruction must recognize diverse sexual orientations including same-sex relationships, teach gender concepts and cover gender expression, gender identity and the harm of negative stereotypes. The health education must include medically accurate, objective information appropriate for students 'of all races, genders, sexual orientations, ethnicities and cultural background,' the state law says. One of the goals is teaching fifth-graders, who are showing the early signs of puberty, to recognize sexual harassment and abuse and report inappropriate touching and child abuse, the school district says. During her talk Saturday, Daly contended that fifth-graders are too early in mental development for lessons about gender identity and the facts of sex. She referred to a student survey question in one curriculum that asks what transgender means. She also objected to proposed instructional content defining different sexualities and genders and what she said was content regarding hormone replacement therapy and masturbation. Daly said there's too much latitude for fifth-grade teachers to talk with students about sexual acts. It's too early for the kids to hear that sex is fun, Daly said, adding that the classroom material is not culturally sensitive to members of the Christian faith. According to the school district FAQ, fifth-grade sex education is widely taught in California to help students navigate the physical changes of puberty and learn the facts in a supportive educational setting. It follows a trend of young people experiencing puberty at younger age and dealing with developments including physical growth, change in voice, acne, body odor, oily hair and the need for good hygiene. To review the copyrighted curriculum materials, parents must go to the district's Department of Curriculum & Instruction, Professional Development Building B, at 1017 Reno Ave., at certain times through June 30. The school board is scheduled to hear more about the curriculum and receive community input Monday evening. The board could approve the curriculum June 23. The school district says parents can opt their children out of the sex education instruction. Forms will be sent home with children at least two weeks before the lessons, and a form will be provided on Parent Square. Daly said the Puberty Talk program is the sister curriculum of the Teen Talk sex education for eighth=grade students. She said local groups including Without Permission could educate students about human trafficking, harassment and other health education topics required by the state.

HIV/AIDS: Facts about the viral infection that attacks the immune system
HIV/AIDS: Facts about the viral infection that attacks the immune system

Yahoo

time7 hours ago

  • Yahoo

HIV/AIDS: Facts about the viral infection that attacks the immune system

When you buy through links on our articles, Future and its syndication partners may earn a commission. QUICK FACTS ABOUT HIV What it is: A lifelong viral infection that weakens the immune system, if left untreated Prevention methods: Taking preventive medicines called PrEP, using condoms, and avoiding needle sharing Treatments: Medicines called antiretroviral therapy (ART) Human immunodeficiency virus (HIV) is a germ that causes a lifelong infection that slowly weakens the immune system. Though the infection is lifelong, medicines can keep the virus in check and help people reach lifespans of near-normal length. However, when people don't have access to those medicines, HIV infections progress to an advanced stage called acquired immunodeficiency syndrome (AIDS), which is fatal within about three years if not treated. When a person has AIDS, most of their key, disease-fighting immune cells are lost. This loss of immune protection leaves the person vulnerable to deadly infections and cancers. Although an HIV diagnosis was once a death sentence, scientists have developed treatments that suppress the virus and enable people to live long lives without transmitting the disease to others. Additionally, there are now effective preventive medications that can dramatically reduce the risk of getting HIV in the first place. There is not yet a widespread cure for HIV/AIDS, although a handful of people have been cured of the infection or are in long-term remission thanks to special stem-cell transplants, specially cell transplants from people who have genes that make them resistant to the virus. Scientists are exploring potential avenues for a cure, which could someday mean that people who contract HIV could be rid of the infection rather than having to take medication for life to manage the disease. HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the end of 2023. Around 630,000 people died from illnesses related to AIDS the same year; by weakening the immune system, AIDS opens the door to these fatal diseases. HIV can spread through contact with an infected person's bodily fluids, although it's important to note that not all bodily fluids can transmit the virus. Bodily fluids that can spread HIV include blood, semen, preseminal fluid, vaginal secretions, breastmilk and rectal discharge (liquid from the anus that's not blood or stool). HIV is not transmitted through saliva, sweat or tears. It's also not spread through the air or through casual contact, such as hugging, shaking hands or sharing food. For transmission to occur, the bodily fluids containing HIV must come into contact with mucous membranes — tissues that line cavities in the body, like the vagina, anus or mouth. The fluids can also transmit HIV when they come into contact with cuts or sores, or when they're introduced to the bloodstream via contaminated needles, for instance. Most people who contract HIV get it through unprotected anal or vaginal sex — meaning sex without a condom or without HIV-preventing medications. People can also contract the virus by sharing the equipment used to inject drugs, such as needles or syringes. Babies can get HIV in the womb, during childbirth or from breastfeeding, if their mother has HIV. People living with HIV who take medicines called ART can suppress the virus to the point that it can't spread via sex. These "virally suppressed" people also have a much lower chance of transmitting HIV to their kids via pregnancy, childbirth or breastfeeding. They are also less likely to spread the virus via shared injection equipment, although experts aren't sure exactly how much the risk is reduced. The symptoms of HIV vary depending on how far the disease has progressed. The virus can spread from one person to another at any stage of the infection, unless the infected person is taking ART and has reached "viral suppression" (see glossary). The initial stage is called "acute HIV infection." Within two to four weeks of contracting the virus, many people develop a flu-like illness involving symptoms like fever, headache, rash and sore throat. These symptoms can last from a few days to a few weeks. Some people have no symptoms at this stage, however. The viral load, or amount of HIV in the blood, at this stage is very high. The second stage of the disease is "chronic HIV infection," during which the virus continues to multiply but at a slower speed than during acute infection. This stage is also called "clinical latency" or "asymptomatic HIV infection," as many people don't feel sick during it. People can remain in this stage of the disease for 10 to 15 years, though some pass through it more quickly. As the virus multiplies, levels of an important type of immune cell — CD4 T lymphocytes — decline. Without treatment, the disease will eventually enter its most advanced stage: AIDS. This can come with a wide range of symptoms, including rapid weight loss; recurring fever; night sweats; extreme tiredness; prolonged swelling of the lymph nodes; diarrhea; sores of the mouth, anus or genitals; and blotches on or under the skin or inside the mouth, nose or eyelids. It can also trigger neurological problems, like memory loss. AIDS raises the risk of severe bacterial infections and cancers, including lymphomas and Kaposi's sarcoma. It can also worsen viral infections, such as hepatitis B and mpox. Without any treatment, people with AIDS typically survive about three years. HIV and AIDS are related, in that AIDS is the most advanced stage of an HIV infection, and therefore, the HIV virus causes both conditions. AIDS can also be called a "stage 3 HIV infection." AIDS is defined in part by a very low CD4 count of fewer than 200 CD4 cells per cubic millimeter (mm3) of blood. Generally speaking, the CD4 counts of healthy teens and adults are around 500 to 1,200 cells/mm3. Anything below 500 cells/mm3 is considered low, and 200 cells/mm3 marks the threshold for an AIDS diagnosis. Doctors also diagnose AIDS by considering a patient's history of "AIDS-defining illnesses." These are medical conditions often seen in people with AIDS because their immune systems can't fight the illnesses off. They include "opportunistic" infections — those caused by germs that wouldn't necessarily harm a person with a well-functioning immune system. Such infections include a fungal infection called extrapulmonary cryptococcosis, recurrent blood infections with Salmonella bacteria, the parasitic infection toxoplasmosis, and lower respiratory infections caused by the herpes simplex virus. The bacterial disease tuberculosis poses a major risk to people with AIDS, and it is currently the leading cause of death for people living with HIV/AIDS worldwide. AIDS-defining illnesses also include cancers such as Kaposi's sarcoma, Burkitt's lymphoma and invasive cervical cancer. Others include HIV encephalopathy, which affects brain function, and HIV wasting syndrome, which causes extreme weight loss and weakness. Complications of AIDS-defining illnesses raise the risk of death, but the degree of risk varies among diseases. At all three stages of the infection, HIV is treated with antiretroviral therapy (ART) — combinations of medications that drive down the amount of HIV in the blood. Different ART drugs work in different ways to keep the amount of virus, or viral load, in check. They are available as daily pills or as shots given periodically throughout the year, depending on the person's treatment plan. It's key for patients to take their medication as prescribed, because missing pills or shots can open the door for the virus to multiply, as well as develop drug resistance, which causes the medication to work less well. ART medications can also interact with other drugs and carry some risk of serious side effects, so patients work with their medical providers to figure out which drug combination is best for them. The goal of ART is "viral suppression," which describes when a person's viral load falls low enough that there are 200 or fewer copies of the virus's genetic material per milliliter (mL) of blood. Historically, tests weren't sensitive enough to detect levels of HIV below that threshold, so doctors called this level "undetectable." Studies also found that people who reach viral suppression can't transmit the virus via sex; have a lower chance of spreading the virus through pregnancy, childbirth or breastfeeding; and likely have a lower chance of spreading it through needle sharing. This is why the slogan "undetectable equals untransmittable," or "U = U," was coined. Nowadays, some tests for HIV are extremely sensitive, so they can detect viral loads significantly below 200 copies/mL. However, experts emphasize that 200 copies/mL is still the critical threshold at which transmission risk becomes extremely low. If a person with HIV/AIDS develops another medical condition, such as an AIDS-defining illness, the individual would receive treatment for that condition in addition to their ART regimen. There is no widespread cure for HIV/AIDS. However, a handful of people have been cured of their HIV infections through stem cell transplants, and a few more are considered "potentially" cured via the same process. Stem cells can develop into different types of cells in the body. In certain cancers that affect blood cells, stem cell transplants can be used to replace the cells lost in the course of cancer treatments such as chemotherapy. Each individual who has been cured of HIV also had one of these cancers, so their doctors searched for stem cell donors who carry a rare gene that makes them resistant to HIV infection. By swapping in cells from an HIV-resistant individual, the procedure essentially locks the virus out of the patient's CD4 cells. There is one exception to this rule: A person known as the "Geneva patient" was potentially cured of HIV after a stem cell transplant, but the donor didn't have this special genetic resistance. It's unclear exactly why the man entered long-term remission from the infection after this procedure, but scientists are investigating. There have also been a couple of cases in which people's own immune systems somehow rallied against the virus and controlled it without treatment; these people are known as "elite controllers." Scientists hope to learn from both the stem cell recipients and from elite controllers to discover cures that could reach far more people with HIV/AIDS. Meanwhile, some researchers are exploring the use of gene-editing tools like CRISPR to cure the infection, while others are investigating the use of drugs and modified immune cells. Antiretroviral therapy (ART) – Combinations of medications that lower the amount of HIV in a person's blood. These drugs, given as pills or shots, prevent the viral infection from progressing to AIDS and dramatically lower a person's risk of complications and of transmitting the virus to others. Pre-exposure prophylaxis (PrEP) – Medicines that people at risk of being exposed to HIV take to prevent the infection. Viral load – The amount of HIV in a person's blood. This is measured in terms of the number of HIV RNA molecules — the virus's genetic material — found in a milliliter of blood. It's an important way to measure how well ART is working. Viral suppression – When a person's viral load falls to 200 copies/mL or lower. Viral suppression is the goal of ART, as it both lowers a person's likelihood of spreading the virus and extends their lifespan by preventing the infection from progressing to AIDS. CD4 T lymphocyte – A type of white blood cell that helps coordinate the actions of other immune cells to fight infections. HIV infects CD4 cells and uses them to multiply while the virus depletes the number of CD4 cells in the body. Image 1 of 4 In the 1980s and 1990s, groups organized "die-ins" to protest the lack of U.S. government attention to the ongoing HIV/AIDS crisis. Die-ins were also conducted to push for support for research to uncover effective treatments and, once treatments were discovered, to demand that those drugs be released to the public. The AIDS Coalition to Unleash Power — known as ACT UP — was a major force behind such protests and remains an active organization today. Image 2 of 4 Kaposi's sarcoma, an example of an AIDS-defining illness, characteristically causes big, purple patches or nodules to appear on the skin and mucous membranes. Image 3 of 4 The public health slogan "U = U," depicted on this sign, refers to the fact that people living with HIV who have undetectable viral loads cannot transmit the virus to others via sex. It stands for "undetectable = untransmittable." Image 4 of 4 The "Berlin patient," pictured here, was the first person cured of HIV via a stem cell transplant. His name was later revealed to be Timothy Ray Brown. Brown went on to launch a foundation under his name that was dedicated to fighting HIV/AIDS. We could end the AIDS epidemic in less than a decade. Here's how. In a 1st, HIV vaccine triggers rare and elusive antibodies in humans Nearly 3 million extra deaths by 2030 could result from HIV funding cuts, study suggests

U.S. aid cuts leave $11 million in birth control supplies for Sub-Saharan Africa stranded
U.S. aid cuts leave $11 million in birth control supplies for Sub-Saharan Africa stranded

Business Insider

time10 hours ago

  • Business Insider

U.S. aid cuts leave $11 million in birth control supplies for Sub-Saharan Africa stranded

Millions of contraceptives intended to support women across Africa are reportedly sitting idle in warehouses and are at risk of being destroyed due to delays and funding cuts from the United States government. Millions of contraceptives intended for Africa are at risk of expiration due to U.S. government delays and funding cuts. The supplies, valued at $11 million, include various contraceptive tools meant for low-income countries. The delayed distribution may lead to increased health risks and strain on the healthcare systems in Africa. A former US official and aid worker revealed that the contraceptives, valued at around $11 million, include condoms, birth control pills, implants, and intrauterine devices (IUDs), which were originally intended to help women in low-income countries, particularly in sub-Saharan Africa, avoid unplanned pregnancies and protect themselves from sexually transmitted infections like HIV. However, the supplies are now stuck in storage facilities in Belgium and Dubai. According to sources at Reuters, the U.S. The Agency for International Development (USAID) has decided not to pay for their delivery and is no longer donating them as part of foreign aid programs. This delay stems from policy changes implemented by the former U.S. President Donald Trump, who reduced foreign assistance under his 'America First' approach: USAID gives update A recent internal memo from USAID, dated April, highlighted the urgent need to transfer the stock to prevent waste and minimize further costs. Despite this warning, a concrete plan has yet to be announced. With each passing month, the contraceptives edge closer to expiration. A senior U.S. State Department officials further confirmed that the contraceptives remain in storage, but no final decision has been made regarding their fate. The situation, according to the US official, is both frustrating and urgent for many health workers and aid groups. Another former USAID official said the stalled shipment represents nearly 20% of all contraceptives the U.S. usually donates each year, adding that if no solution is found soon, the entire stock could be destroyed, at a cost of hundreds of thousands of dollars. 'These supplies were meant to help women who have little or no access to family planning—girls fleeing conflict, mothers in refugee camps, and young women at risk of early pregnancy, ' one source said. ' The condoms in the shipment were also meant to help prevent the spread of HIV, which continues to impact millions across the region.' It added. Karen Hong, head of supply chain at the United Nations Population Fund (UNFPA), said her team is already working on an alternative plan. ' We cannot dwell on an issue for too long; when urgency and clarity don't align, we have to move on,' she said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store